PubRank

H H Newball

Author PubWeight™ 46.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974 4.31
2 Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol 1975 2.74
3 Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest 1975 2.04
4 Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981 1.86
5 Human lung mast cells: purification and characterization. J Immunol 1982 1.78
6 Generation of leukotrienes by purified human lung mast cells. J Clin Invest 1982 1.77
7 Collateral ventilation in man. N Engl J Med 1978 1.47
8 Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest 1980 1.32
9 Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization. J Clin Invest 1979 1.20
10 Separation of slow reacting substance of anaphylaxis (SRS-A) from human lung into four biologically active fractions. J Immunol 1976 1.19
11 Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis 1982 1.14
12 Comparative studies of human basophils and mast cells. Fed Proc 1983 1.11
13 Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis 1977 1.10
14 Anaphylactic release of prostaglandins from human lung in vitro. Am Rev Respir Dis 1980 1.08
15 Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol 1984 1.07
16 Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol 1982 1.02
17 Release of leukocyte kallikrein mediated by IgE. Nature 1975 0.98
18 Anaphylactic relase of a basophil kallikrein-like activity. II. A mediator of immediate hypersensitivity reactions. J Clin Invest 1979 0.96
19 Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am Rev Respir Dis 1985 0.93
20 The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Chest 1982 0.93
21 Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest 1985 0.91
22 Platelet activation in antigen-induced bronchoconstriction. N Engl J Med 1981 0.86
23 Effect of elevated triglycerides on the diffusing capacity of man. Am Rev Respir Dis 1975 0.86
24 Myasthenia gravis. Ann Intern Med 1974 0.86
25 Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: an ultrastructural and functional correlation. Electron Microsc Rev 1992 0.86
26 Activation of Hageman factor by proteases released during antigen challenge of human lung. Trans Assoc Am Physicians 1981 0.84
27 Anaphylactic release of a prekallikrein activator from human lung in vitro. J Clin Invest 1983 0.84
28 Relative effects of bradykinin and histamine on the respiratory system of man. J Appl Physiol 1973 0.83
29 Effects of endotoxin on expression of VLA integrins by human bronchoalveolar lavage macrophages. J Leukoc Biol 1995 0.83
30 Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation 1989 0.83
31 Basophil mediators and their release, with emphasis on BK-A. J Invest Dermatol 1980 0.81
32 Purified human basophils and mast cells: current concepts of mediator release. Eur J Respir Dis Suppl 1983 0.81
33 Bradykinin and human airways. Respir Physiol 1975 0.80
34 Mast cells and basophils: effector cells of inflammatory disorders in the lung. Thorax 1981 0.79
35 The unreliability of the maximal midexpiratory flow as an index of acute airway changes. Chest 1975 0.79
36 Activation of human Hageman factor by a leukocytic protease. Adv Exp Med Biol 1979 0.78
37 Organophosphate-induced histamine release from mast cells. J Pharmacol Exp Ther 1986 0.78
38 Follow-up respiratory function of a patient treated with a membrane lung. Am Rev Respir Dis 1975 0.78
39 Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis. Thorax 1976 0.75
40 Does reserpine increase prolactin and exacerbate cancer of prostate? Case control study. Urology 1973 0.75
41 The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol 1986 0.75
42 Respiratory response to domestic fibrous glass exposure. Environ Res 1976 0.75
43 BL-5255 II: effects on release and smooth muscle activity of mediators of immediate hypersensitivity reactions. Int Arch Allergy Appl Immunol 1983 0.75
44 Cystic fibrosis presenting as allergic bronchopulmonary aspergillosis. Md State Med J 1982 0.75
45 The influence of atropine and cromolyn on human bronchial hyperreactivity to aerosolized prostaglandin F2 alpha. Respir Physiol 1977 0.75
46 Prostaglandin F-2 alpha functions as a local hormone on human airways. Respir Physiol 1980 0.75
47 Basophil kallikrein of anaphylaxis (BK-A)--purification and characterization. Adv Exp Med Biol 1979 0.75
48 Novel effects of PGF2 alpha on airway function in asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol 1983 0.75
49 Lung volumes and compliance in myasthenia gravis and reversible airway obstruction. Am Rev Respir Dis 1976 0.75
50 Response of asthmatic airways to intravenous bradykinin and histamine. Med Ann Dist Columbia 1974 0.75